학술논문
Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial
Document Type
Article
Author
Hillmen, Peter; Pitchford, Alexandra; Bloor, Adrian; Broom, Angus; Young, Moya; Kennedy, Ben; Walewska, Renata; Furtado, Michelle; Preston, Gavin; Neilson, Jeffrey R; Pemberton, Nicholas; Sidra, Gamal; Morley, Nicholas; Cwynarski, Kate; Schuh, Anna; Forconi, Francesco; Elmusharaf, Nagah; Paneesha, Shankara; Fox, Christopher P; Howard, Dena R; Hockaday, Anna; Brown, Julia M; Cairns, David A; Jackson, Sharon; Greatorex, Natasha; Webster, Nichola; Shingles, Jane; Dalal, Surita; Patten, Piers E M; Allsup, David; Rawstron, Andrew; Munir, Talha
Source
In The Lancet Oncology May 2023 24(5):535-552
Subject
Language
ISSN
1470-2045